Last update 01 Nov 2024

Biotheravision, Inc.

Illinois, United States
|
biotheravision.com

Overview

Tags

Nervous System Diseases
Congenital Disorders
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
M3 receptor(Muscarinic acetylcholine receptor M3)1

Related

1
Drugs associated with Biotheravision, Inc.
Cevimeline Hydrochloride
Target
M3 receptor
Mechanism
M3 receptor agonists
Active Org.
KYE Pharmaceuticals, Inc. [+5]
Originator Org.
Snow Brand Milk Products Co., Ltd.
Active Indication
Sjogren's Syndrome [+4]
Inactive Indication
Alzheimer Disease [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date11 Jan 2000
1
Clinical Trials associated with Biotheravision, Inc.
NCT06543303 / Not yet recruitingPhase 2
A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
100 Clinical Results associated with Biotheravision, Inc.
Login to view more data
0 Patents (Medical) associated with Biotheravision, Inc.
Login to view more data
100 Deals associated with Biotheravision, Inc.
Login to view more data
100 Translational Medicine associated with Biotheravision, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Cevimeline Hydrochloride
 ( M3 receptor )		Dry Eye Syndromes
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free